Teva Pharmaceutical Industries Ltd
TEVA15.655USD
+0.275+1.79%
Horarios del mercado （ET）Cotizaciones retrasadas 15 min
17.96BCap. mercado
PérdidaP/E TTM
Más Datos de Teva Pharmaceutical Industries Ltd Compañía
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Información de la empresa
Símbolo de cotizaciónTEVA
Nombre de la empresaTeva Pharmaceutical Industries Ltd
Fecha de salida a bolsaJan 01, 1951
Director ejecutivoMr. Richard D. Francis
Número de empleados33892
Tipo de seguridadOrdinary Share
Fin del año fiscalJan 01
Dirección124 Dvora Hanevi'a St.
CiudadTEL AVIV-YAFO
Bolsa de valoresTel Aviv Stock Exchange
PaísIsrael
Código postal6944020
Teléfono97239148213
Sitio Webhttps://www.tevapharm.com/
Símbolo de cotizaciónTEVA
Fecha de salida a bolsaJan 01, 1951
Director ejecutivoMr. Richard D. Francis
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Prof. Varda Shalev
Prof. Varda Shalev
Independent Director
Independent Director
22.50K
+74.83%
Ms. Christine (Chris) Fox
Ms. Christine (Chris) Fox
Executive Vice President - U.S. Commercial
Executive Vice President - U.S. Commercial
14.28K
--
Mr. David R. McAvoy
Mr. David R. McAvoy
Executive Vice President, Chief Legal Officer
Executive Vice President, Chief Legal Officer
11.91K
--
Mr. Evan Lippman
Mr. Evan Lippman
Executive Vice President - Business Development
Executive Vice President - Business Development
--
--
Mr. Placid Jover
Mr. Placid Jover
Executive Vice President, Chief Human Resources Officer
Executive Vice President, Chief Human Resources Officer
--
--
Mr. Richard Daniell
Mr. Richard Daniell
Executive Vice President - European Commercial
Executive Vice President - European Commercial
--
--
Mr. Eliyahu Sharon (Eli) Kalif
Mr. Eliyahu Sharon (Eli) Kalif
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
Mr. Matthew Shields
Mr. Matthew Shields
Executive Vice President - Teva Global Operations
Executive Vice President - Teva Global Operations
--
--
Mr. Chen Lichtenstein
Mr. Chen Lichtenstein
Independent Director
Independent Director
--
--
Dr. Sol J. Barer, Ph.D.
Dr. Sol J. Barer, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Prof. Varda Shalev
Prof. Varda Shalev
Independent Director
Independent Director
22.50K
+74.83%
Ms. Christine (Chris) Fox
Ms. Christine (Chris) Fox
Executive Vice President - U.S. Commercial
Executive Vice President - U.S. Commercial
14.28K
--
Mr. David R. McAvoy
Mr. David R. McAvoy
Executive Vice President, Chief Legal Officer
Executive Vice President, Chief Legal Officer
11.91K
--
Mr. Evan Lippman
Mr. Evan Lippman
Executive Vice President - Business Development
Executive Vice President - Business Development
--
--
Mr. Placid Jover
Mr. Placid Jover
Executive Vice President, Chief Human Resources Officer
Executive Vice President, Chief Human Resources Officer
--
--
Mr. Richard Daniell
Mr. Richard Daniell
Executive Vice President - European Commercial
Executive Vice President - European Commercial
--
--
Desglose de ingresos
Divisa: USDActualizado: dom., 6 de jul
Divisa: USDActualizado: dom., 6 de jul
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
Por negocioUSD
Nombre
Ganancia
Proporción
Generic products
2.31B
59.26%
AUSTEDO
411.00M
10.56%
Anda
373.00M
9.59%
Other
220.00M
5.65%
AJOVY
139.00M
3.57%
Other
442.00M
11.36%
Por regiónUSD
Nombre
Ganancia
Proporción
United States
1.91B
49.06%
Europe
1.19B
30.69%
International Markets
582.00M
14.96%
Other
205.00M
5.27%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Generic products
2.31B
59.26%
AUSTEDO
411.00M
10.56%
Anda
373.00M
9.59%
Other
220.00M
5.65%
AJOVY
139.00M
3.57%
Other
442.00M
11.36%
Estadísticas de accionistas
Actualizado: sáb., 12 de jul
Actualizado: sáb., 12 de jul
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Fidelity Management & Research Company LLC
6.56%
Menora Mivtachim Insurance Ltd.
5.00%
Ion Asset Management Israel Ltd
3.40%
Clal Insurance Enterprises Holdings Ltd.
3.29%
Phoenix Investment and Finances Ltd
3.29%
Other
78.44%
Accionistas
Accionistas
Proporción
Fidelity Management & Research Company LLC
6.56%
Menora Mivtachim Insurance Ltd.
5.00%
Ion Asset Management Israel Ltd
3.40%
Clal Insurance Enterprises Holdings Ltd.
3.29%
Phoenix Investment and Finances Ltd
3.29%
Other
78.44%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
27.60%
Hedge Fund
13.28%
Investment Advisor/Hedge Fund
11.76%
Insurance Company
7.31%
Research Firm
2.85%
Pension Fund
1.82%
Family Office
1.32%
Bank and Trust
0.82%
Sovereign Wealth Fund
0.22%
Other
33.01%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
1097
737.27M
64.27%
-2.94M
2025Q1
1130
727.69M
63.46%
-282.41K
2024Q4
1087
683.52M
59.66%
-22.86M
2024Q3
1029
663.95M
58.60%
-6.13M
2024Q2
1002
631.05M
55.72%
-26.20M
2024Q1
950
595.83M
53.15%
-34.73M
2023Q4
932
601.27M
53.63%
+7.51M
2023Q3
929
573.53M
51.16%
-84.22M
2023Q2
921
512.98M
45.79%
-122.32M
2023Q1
927
576.84M
51.93%
-50.26M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Fidelity Management & Research Company LLC
75.30M
6.57%
-710.45K
-0.93%
Mar 31, 2025
Menora Mivtachim Insurance Ltd.
29.19M
2.55%
+808.07K
+2.85%
Mar 31, 2025
Ion Asset Management Israel Ltd
39.03M
3.4%
+2.38M
+6.50%
Mar 31, 2025
Clal Insurance Enterprises Holdings Ltd.
37.79M
3.3%
-1.17M
-3.00%
Mar 31, 2025
Phoenix Investment and Finances Ltd
27.46M
2.39%
+6.25M
+29.47%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
33.06M
2.88%
-39.31K
-0.12%
Mar 31, 2025
Lingotto Investment Management LLP
27.85M
2.43%
+661.55K
+2.43%
Mar 31, 2025
Migdal Insurance and Financial Holdings Ltd
26.34M
2.3%
+300.00K
+1.15%
Mar 31, 2025
Rubric Capital Management LP
25.55M
2.23%
+8.55M
+50.29%
Mar 31, 2025
Harel Insurance Investments and Financial Services Ltd
22.06M
1.92%
+22.04M
+197885.16%
Mar 31, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 2 de ago
Actualizado: sáb., 2 de ago
Nombre
Proporción
VanEck Israel ETF
6.53%
iShares MSCI Israel ETF
6.2%
Amplify Weight Loss Drug & Treatment ETF
5.06%
Tema Neuroscience and Mental Health ETF
4.99%
ARK Israel Innovative Technology ETF
1.74%
VanEck Pharmaceutical ETF
1.6%
WisdomTree International Multifactor Fund
0.55%
iShares Health Innovation Active ETF
0.49%
iShares MSCI Intl Value Factor ETF
0.4%
Fidelity New Millennium ETF
0.2%
Ver más
VanEck Israel ETF
Proporción6.53%
iShares MSCI Israel ETF
Proporción6.2%
Amplify Weight Loss Drug & Treatment ETF
Proporción5.06%
Tema Neuroscience and Mental Health ETF
Proporción4.99%
ARK Israel Innovative Technology ETF
Proporción1.74%
VanEck Pharmaceutical ETF
Proporción1.6%
WisdomTree International Multifactor Fund
Proporción0.55%
iShares Health Innovation Active ETF
Proporción0.49%
iShares MSCI Intl Value Factor ETF
Proporción0.4%
Fidelity New Millennium ETF
Proporción0.2%
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
